Arachidonoyl PAF C-16 (1-O-hexadecyl-2-Arachidonoyl-sn-glycero-3-Phosphocholine)
98%
- Product Code: 55296
CAS:
86288-11-1
| Molecular Weight: | 768.1 g./mol | Molecular Formula: | C₄₄H₈₂NO₇P |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | -20°C, airtight, dry |
Product Description:
This compound is primarily utilized in biochemical research to study the mechanisms of platelet-activating factor (PAF) signaling pathways. It serves as a synthetic analog of PAF, enabling scientists to investigate its role in inflammation, immune responses, and cellular communication. Researchers use it to explore its effects on platelet aggregation, vascular permeability, and interactions with PAF receptors in various cell types. Additionally, it is employed in lipidomics studies to understand the behavior of phospholipids in biological membranes and their involvement in disease processes such as atherosclerosis and allergic reactions. Its application extends to drug development, where it aids in screening potential inhibitors of PAF-mediated pathways.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.005 | 10-20 days | ฿39,717.00 |
+
-
|
Arachidonoyl PAF C-16 (1-O-hexadecyl-2-Arachidonoyl-sn-glycero-3-Phosphocholine)
This compound is primarily utilized in biochemical research to study the mechanisms of platelet-activating factor (PAF) signaling pathways. It serves as a synthetic analog of PAF, enabling scientists to investigate its role in inflammation, immune responses, and cellular communication. Researchers use it to explore its effects on platelet aggregation, vascular permeability, and interactions with PAF receptors in various cell types. Additionally, it is employed in lipidomics studies to understand the behavior of phospholipids in biological membranes and their involvement in disease processes such as atherosclerosis and allergic reactions. Its application extends to drug development, where it aids in screening potential inhibitors of PAF-mediated pathways.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :